Zymeworks (ZYME) EBITDA Margin Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -114,157.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114,157.00 |
| Dec 31, 2025 | -156,086.00 |
| Sep 30, 2025 | 9,741.00 |
| Jun 30, 2025 | 47,822.00 |
| Mar 31, 2025 | -38,582.00 |
| Dec 31, 2024 | -327.00 |
| Sep 30, 2024 | 208.00 |
| Jun 30, 2024 | 28,397.00 |
| Mar 31, 2024 | -26,033.00 |
| Dec 31, 2023 | -17,076.00 |
| Sep 30, 2023 | 164,181.00 |
| Jun 30, 2023 | 43,011.00 |
| Mar 31, 2023 | 372,402.00 |
| Dec 31, 2022 | 58,461.00 |
| Sep 30, 2022 | -44,019.00 |